Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Lorente

Showing results (21-30 of 75) with videos related to

Pageof 8
Sort By:
Nature Reviews. Urology|January 8, 2015
Switching and withdrawing hormonal agents for castration-resistant prostate cancerDavid Lorente, Joaquin Mateo, Zafeiris Zafeiriou, et al.
Journal of Thoracic Disease|May 1, 2018
Early radiological response as predictor of overall survival in non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor mutationsCarmen Salvador-Coloma, David Lorente, Sarai Palanca, et al.
Scandinavian Journal of Urology|January 11, 2019
The role of negative magnetic resonance imaging: can we safely avoid biopsy in P.I.-R.A.D.S. 2 as in P.I.-R.A.D.S. 1?Lucas Regis, Ana Celma, Jacques Planas, et al.
Clinical Genitourinary Cancer|June 14, 2017
Neutrophil to Lymphocyte Ratio in Castration-Resistant Prostate Cancer Patients Treated With Daily Oral CorticosteroidsNiven Mehra, Adam Sharp, David Lorente, et al.
Scandinavian Journal of Urology|September 16, 2016
Hormonal response recovery after long-term androgen deprivation therapy in patients with prostate cancerJacques Planas, Ana Celma, José Placer, et al.
European Urology|December 3, 2014
A randomised phase 2 trial of dexamethasone versus prednisolone in castration-resistant prostate cancerRamachandran Venkitaraman, David Lorente, Vedang Murthy, et al.
Minerva Urology and Nephrology|April 23, 2021
Surgeon preimplantation macroscopic graft appraisal improves risk stratification of deceased kidney donors: a prospective studyEnric Miret Alomar, Francesc Moreso, Nestor Toapanta, et al.
Neuroscience and Biobehavioral Reviews|December 24, 2022
Crosstalk between Mu-Opioid receptors and neuroinflammation: Consequences for drug addiction and painJavier Cuitavi, Jose Vicente Torres-Pérez, Jesús David Lorente, et al.
Frontiers in Oncology|October 21, 2022
Update in collecting duct carcinoma: Current aspects of the clinical and molecular characterization of an orphan diseaseCristina Suarez, David Marmolejo, Augusto Valdivia, et al.
European Journal of Cancer (Oxford, England : 1990)|January 18, 2014
Reply to: Enzalutamide after failure of docetaxel and abiraterone in metastatic castrate resistant prostate cancerDavid Lorente, Diletta Bianchini, Alejo Rodriguez-Vida, et al.
Pageof 8

Showing results (21-30 of 75) with videos related to

Sort By:
Pageof 8
Nature Reviews. Urology|January 8, 2015
Switching and withdrawing hormonal agents for castration-resistant prostate cancerDavid Lorente, Joaquin Mateo, Zafeiris Zafeiriou, et al.
Journal of Thoracic Disease|May 1, 2018
Early radiological response as predictor of overall survival in non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor mutationsCarmen Salvador-Coloma, David Lorente, Sarai Palanca, et al.
Scandinavian Journal of Urology|January 11, 2019
The role of negative magnetic resonance imaging: can we safely avoid biopsy in P.I.-R.A.D.S. 2 as in P.I.-R.A.D.S. 1?Lucas Regis, Ana Celma, Jacques Planas, et al.
Clinical Genitourinary Cancer|June 14, 2017
Neutrophil to Lymphocyte Ratio in Castration-Resistant Prostate Cancer Patients Treated With Daily Oral CorticosteroidsNiven Mehra, Adam Sharp, David Lorente, et al.
Scandinavian Journal of Urology|September 16, 2016
Hormonal response recovery after long-term androgen deprivation therapy in patients with prostate cancerJacques Planas, Ana Celma, José Placer, et al.
European Urology|December 3, 2014
A randomised phase 2 trial of dexamethasone versus prednisolone in castration-resistant prostate cancerRamachandran Venkitaraman, David Lorente, Vedang Murthy, et al.
Minerva Urology and Nephrology|April 23, 2021
Surgeon preimplantation macroscopic graft appraisal improves risk stratification of deceased kidney donors: a prospective studyEnric Miret Alomar, Francesc Moreso, Nestor Toapanta, et al.
Neuroscience and Biobehavioral Reviews|December 24, 2022
Crosstalk between Mu-Opioid receptors and neuroinflammation: Consequences for drug addiction and painJavier Cuitavi, Jose Vicente Torres-Pérez, Jesús David Lorente, et al.
Frontiers in Oncology|October 21, 2022
Update in collecting duct carcinoma: Current aspects of the clinical and molecular characterization of an orphan diseaseCristina Suarez, David Marmolejo, Augusto Valdivia, et al.
European Journal of Cancer (Oxford, England : 1990)|January 18, 2014
Reply to: Enzalutamide after failure of docetaxel and abiraterone in metastatic castrate resistant prostate cancerDavid Lorente, Diletta Bianchini, Alejo Rodriguez-Vida, et al.
Pageof 8